NCORP recognizes Kathleen Yost Butler, Kamara Mertz-Rivera, Jordan Vogelsberg with 2025 awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The NCI Community Oncology Research Program selected Kathleen Yost Butler and Kamara Mertz-Rivera as recipients of this year’s outstanding principal investigator and administrator, respectively, at the 2025 NCORP annual meeting in Bethesda. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has been approved for research funding by the Patient-Centered Outcomes Research Institute to study whether adding chemotherapy before standard treatment with immunotherapy, radiation, and surgery for certain sarcomas will reduce the risk of the cancer returning.
Curebound has announced eight grants for a total of $2 million in funding. The funding is made available through two new Curebound programs: Catalyst Grants, which support projects within early-stage life science companies that are seeking to take innovative discoveries to commercially approved products, and Equity Grants, which focus on overcoming disparities in cancer research and treatment in underserved populations.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login